Pharmacologic therapy to reduce fracture risk: comment on the clinical practice guidelines of the ACP.
Lewiecki
E Michael
EM
University of New Mexico School of Medicine and Osteoporosis and New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM 87106, USA. lewiecki@aol.com
D050723:Fractures, Bone / Q000517:prevention & control*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D017410:Practice Guidelines as Topic